Search results
My educational and research background is in genetics and cellular and molecular biology. However, I have written about a broad array of science and technology topics, including biomedical engineering, chemistry, synthetic biology, public health, bioethics, science policy, biotechnology and intellectual property (among other subjects).
Sep 14, 2023 · By Michael Eisenstein 14 September 2023 | Part of Nature Outlook: Robotics and artificial intelligence Judged as an artwork, GPT-4’s unicorn won’t win any prizes.
Michael Eisenstein. PMID: 37072518 DOI: 10.1038/d41586-023-01300-w No abstract available. Keywords: Computational biology and bioinformatics; ...
Michael Eisenstein. ... R Stewart, M Eisenstein, J Chambers, JD Marth, ... Proceedings of the National Academy of Sciences 110 (46), 18460-18465, 2013. 163: 2013:
Apr 4, 2024 · Land Capital's mission is centered on enhancing the liquidity of land through various strategic actions. The company positions itself as a catalyst in the land development process, focusing on the design and future potential of land.
Oct 12, 2017 · Offering long reads and rapidly improving accuracy, nanopore sequencing has the potential to upend the DNA sequencing market. Scott Tighe (left) and David Goerlitz use the MinION device to sequence...
Science writer and editor. Done with this place. Find me on BlueSky, same name. Contact Michael, search articles and Tweets, monitor coverage, and track replies from one place. I prefer pitches via email. I occasionally check newswires for new story ideas.
